NO20012831L - Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom - Google Patents

Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom

Info

Publication number
NO20012831L
NO20012831L NO20012831A NO20012831A NO20012831L NO 20012831 L NO20012831 L NO 20012831L NO 20012831 A NO20012831 A NO 20012831A NO 20012831 A NO20012831 A NO 20012831A NO 20012831 L NO20012831 L NO 20012831L
Authority
NO
Norway
Prior art keywords
diazepinoindoles
treatment
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
NO20012831A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012831D0 (no
Inventor
Annette Doherty
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20012831D0 publication Critical patent/NO20012831D0/no
Publication of NO20012831L publication Critical patent/NO20012831L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20012831A 2000-06-09 2001-06-08 Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom NO20012831L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00401646A EP1161949A1 (en) 2000-06-09 2000-06-09 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease

Publications (2)

Publication Number Publication Date
NO20012831D0 NO20012831D0 (no) 2001-06-08
NO20012831L true NO20012831L (no) 2001-12-10

Family

ID=8173724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012831A NO20012831L (no) 2000-06-09 2001-06-08 Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom

Country Status (19)

Country Link
US (1) US6544983B2 (cs)
EP (1) EP1161949A1 (cs)
JP (1) JP2002138090A (cs)
KR (1) KR20010111457A (cs)
CN (1) CN1345725A (cs)
AR (1) AR030291A1 (cs)
AU (1) AU5181301A (cs)
BR (1) BR0102289A (cs)
CA (1) CA2347337A1 (cs)
CZ (1) CZ20011999A3 (cs)
EA (1) EA200100515A3 (cs)
HU (1) HUP0102388A3 (cs)
IL (1) IL143636A0 (cs)
MX (1) MXPA01005726A (cs)
NO (1) NO20012831L (cs)
NZ (1) NZ512222A (cs)
PL (1) PL347922A1 (cs)
SK (1) SK7832001A3 (cs)
ZA (1) ZA200104616B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
US20070167450A1 (en) * 2003-11-20 2007-07-19 Astellas Pharma Inc. Agent for treating chronic pelvic pain syndrome
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
AU2007274054B2 (en) 2006-07-10 2012-05-24 Paion Uk Limited Benzodiazepine salts
JP5240205B2 (ja) 2008-01-11 2013-07-17 アステラス製薬株式会社 精巣の疼痛又は不快感行動及び頻尿併発モデル動物
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
MA37581B1 (fr) * 2012-05-22 2016-07-29 Paion Uk Ltd Compositions comprenant des benzodiazépines à action rapide
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652352A1 (fr) 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
FR2725719B1 (fr) 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
FR2746800B1 (fr) * 1996-03-29 1998-06-05 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases 4
FR2762841B1 (fr) 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv

Also Published As

Publication number Publication date
EA200100515A3 (ru) 2002-06-27
CA2347337A1 (en) 2001-12-09
JP2002138090A (ja) 2002-05-14
NO20012831D0 (no) 2001-06-08
EP1161949A1 (en) 2001-12-12
IL143636A0 (en) 2002-04-21
EA200100515A2 (ru) 2001-12-24
KR20010111457A (ko) 2001-12-19
HUP0102388A2 (hu) 2002-04-29
PL347922A1 (en) 2001-12-17
AR030291A1 (es) 2003-08-20
NZ512222A (en) 2002-10-25
CZ20011999A3 (cs) 2002-04-17
US20020010175A1 (en) 2002-01-24
CN1345725A (zh) 2002-04-24
BR0102289A (pt) 2002-03-12
HUP0102388A3 (en) 2004-11-29
AU5181301A (en) 2001-12-13
MXPA01005726A (es) 2003-08-20
US6544983B2 (en) 2003-04-08
SK7832001A3 (en) 2002-05-09
HU0102388D0 (en) 2001-08-28
ZA200104616B (en) 2002-10-30

Similar Documents

Publication Publication Date Title
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
NO20052883L (no) Nye medikamenter for behandling av kronisk obstruktiv luftveissykdom.
DE60317198D1 (de) Proteinkinaseinhibitoren
NO20062292L (no) Fremgangsmate for behandling av transplantasjonsavstoting
DE60331187D1 (de) Kinaseinhibitoren
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20045247L (no) Nukleosidderivater for behandling av hepatitt C-virusinfeksjon
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
GB0111523D0 (en) Chemical compounds
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
NO20041452L (no) 17-beta-hydroksysteroid-dehydrogenase type 3-inhibitorer for behandling av androgenavhengige sykdommer.
DE60009511D1 (de) Nematizide trifluorbutene
DE60121461D1 (de) Kondensierte pyridoindolderivate
NO20012831L (no) Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
NO20050073L (no) Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
NO20044526L (no) Hemisterlinderivater og anvendelser derav
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
NO20051404L (no) Pyridylsubstituerte heterocykluser som er nyttige for behandling eller forebyggelse av HCV infeksjon
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
NO20052698L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
DE60112960D1 (de) Kondensierte pyridoindolderivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application